Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy

Jorge E. Cortes*, Moshe Talpaz, Francis Giles, Susan O'Brien, Mary Beth Rios, Jianqin Shan, Guillermo Garcia-Manero, Stefan Faderl, Deborah A. Thomas, William Wierda, Allessandra Ferrajoli, Sima Jeha, Hagop M. Kantarjian

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

205 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology